期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

围手术期的安全抗凝 被引量：7

原文传递
导出
摘要 近年来，南于心、脑血管疾病发病率逐年增高，越来越多的患者接受长期的口服抗凝药物（Oral anticoagulant，OAC）治疗。抗凝药物主要应用于血栓性疾病及容易形成血栓栓塞的高危险人群中，如房颤患者、心脏瓣膜置换术后、
作者 连利珊 李拥军
机构地区 中国医学科学院
出处 《国际外科学杂志》 2012年第12期804-807,共4页 International Journal of Surgery
关键词 口服抗凝药物 围手术期 心脏瓣膜置换术后 安全 房颤患者 疾病发病率 高危险人群 血栓性疾病
分类号 R619 [医药卫生—外科学]
  • 相关文献

参考文献30

  • 1Baudo F, de Cataldo F, Mostarda G, et al. Management of patients on long-time oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulant clinics [J]. Intern Emerg Med, 2007, 2(4) : 280-284. 被引量：1
  • 2Siegal D, Yudin J, Kaatz S, et al. Periprocedural heparin bridging in patients receiving K antagonists: systematic review and meta-a- nalysis of bleeding and thromboembnlic rates [ J]. Circulation, 2012, 126(13): 1630-1639. 被引量：1
  • 3Spyropoulos AC, Turpie AG, Dunn AS, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry [ J ]. J Thromb Haemost, 2006, 4 ( 6 ) : 1246-1252. 被引量：1
  • 4Guyatt GH, Norris SL, Schulman S, et al. Methodology for the de- velopment of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141 (2 Suppl) : 53S-70S. 被引量：1
  • 5Halbritter KM, Wawer A, Beyer J, et al. Bridging anticoagulation for patients on long-term vitamin-K-antagonists: a prospective 1 year registry of 311 episodes [ J]. J Thromb Haemost, 2005, 3 (12) : 2823-2825. 被引量：1
  • 6Spyropoulos AC, Douketis JD, Gorotziafas G, et al. Periprocedural an- tithrombotic and bridging therapy: recommendation for standm'dized re- porting in patients with arterial indications for chronic oral anticoagulant therapy[J]. J Thromb Haemost, 2012, 10(4) : 692-694. 被引量：1
  • 7Matsuoka T, Inoue K, Mizuno K, et al. Herprin as bridging antico- agulant and antiplatelet therapy during the perioperative period[ J]. Hinyokika Kiyo, 2012, 58(5): 223-226. 被引量：1
  • 8Ganter MT, Hofer CK. Principles of perioperative coagulant man- agement[J]. Unfallchirurg, 2012, 115(4): 353-362. 被引量：1
  • 9O' Donnell M, Oczkowski W, Fang J, et al. Preadmission an- tithrombotic treatment and stroke severity in patients with atrial fi- brillation and acute ischaemic stroke : an observational study [ J ]. Lancet Neurol, 2006, 5 (9): 749-754. 被引量：1
  • 10Garwood CL, Hwang JM, Moser LR, et al. Striking a balance be- tween the risks and benefits of anticoagulation bridge therapy in pa- tients with atrial fibrillation: Clinical updates and remaining contro- versies[J]. Pharmacotherapy, 2011, 31 (12): 1208-1220. 被引量：1

二级参考文献82

  • 1邱贵兴,戴尅戎,杨庆铭,裴福兴,陈百成,曾炳芳,陈安民,王坤正,王继芳,余楠生,周乙雄,孙天胜,刘强,胡永成.预防骨科大手术后深静脉血栓形成的专家建议——深静脉血栓形成预防座谈会纪要[J].中华骨科杂志,2005,25(10):636-640. 被引量：477
  • 2Mantilla CB, Horlocker TT, Schroeder DR, et al. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty[J]. Anesthesiology, 2002, 96(5):1140-1146. 被引量：1
  • 3Anderson FA Jr, Hirsh J, White K, et al. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001 : findings from the Hip and Knee Registry[J]. Chest, 2003, 124 (6 Suppl) :349-356. 被引量：1
  • 4Mauermann WJ, Shiling AM, Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis [ J ]. A nesth A nalg, 2006, 103 ( 4 ) : 1018 - 1025. 被引量：1
  • 5Rashiq S, Finegan BA. The effect of spinal anesthesia on blood transfusion rate in total joint arthroplasty[ J]. Can J Surg, 2006, 49 (6) :391-396. 被引量：1
  • 6Horlocker TT. Low molecular weight heparin and neuraxial anesthesia[J]. Thromb Res, 2001, 101 (1) : 141-154. 被引量：1
  • 7Nicolaides AN, Breddin HK, Fareed J, et al. Prevention of venous thromboembolism: international consensus statement: guidelines compiled in accordance with the scientific evidence [ J ]. lnt Angiol, 2001, 20(1) :1-37. 被引量：1
  • 8Hull RD, Pineo GF, Brant RF, et al. Long-term low molecularweight heparin versus usual care in proximal-vein thrombosis patients with cancer[J]. Am J Med, 2006, 119(12) : 1062-1072. 被引量：1
  • 9Lopez JA, Kearon C, Lee AY. Deep venous thrombosis[J]. Hematology Am Soc Hematol Educ Program, 2004, (1) : 439-456. 被引量：1
  • 10Scarvelis D, Wells PS. Diagnosis and treatment of deepvein thrombosis[J]. CMAJ, 2006, 175(9) : 1087-1092. 被引量：1

共引文献20

同被引文献88

  • 1郁正亚.围手术期抗凝药物的使用[J].中华临床医师杂志（电子版）,2011,5(16):4778-4783. 被引量：12
  • 2Geerts WH, Berqqvist D, Pineo GF, et al. Prevention of Venous Thromboembolism: American College of Chest Physicians Evi- dence-Baaed Clinical Practice Guidelines(8th Edition)[J]. Chest, 2008,133(6 Suppl):381-453. 被引量：1
  • 3Hill J, Treasure T. Reducing the risk of venous thromboembo- lism (deep vein thrombosis and pulmonatry embolism) in inpa- tients having surgery: summary of NICE guidance [J~. BMJ, 2007,334(7602):1053-1054. 被引量：1
  • 4Leizoroviez A. SMART Venography study steering committee. Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study [J]. Haematologica, 2007,92(9): 1194-1200. 被引量：1
  • 5Sakon M, Machara Y, Yoshikawa H, et al. Incidence of venous thromboembolism following major abdominal surgery: multi-center, prospective epidemiological study in Japan [J]. J Thromb Haemost, 2006,4(3):581-586. 被引量：1
  • 6Shah DR, Wang H, Bold R J, et al. Nomograms to predict risk of in-hospital and post-discharge venous thromboembolism after abdominal and thoracic surgery: an American College of Sur- geons National Surgical Quality Improvement Program analysis [J]. J Surg Res, 2013,183(1):462-471. 被引量：1
  • 7Gould MK, Gareia DA, Wren SM. prevention of VTE in nonor- thopedic surgical patients: antithrombotic therapy and preven- tion of thrombosis. 9th ed[J]. Chest, 2012,141:e227S-e277S. 被引量：1
  • 8De Martino RR, Goodney PP, Spangler EL, et al. Variation in thromboembolic complications among patients undergoing com- monly performed cancer operations [J]. J Vasc Surg, 2012,55(4): 1035-1040. 被引量：1
  • 9Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer[J]. J Clin Oncol, 2007(25):5490-5505. 被引量：1
  • 10Kuter DJ. Thrombotic complications of central venous catheters in cancer patients [ J ]. Oncologist, 2004(9):207-216. 被引量：1

引证文献7

二级引证文献462

国际外科学杂志
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部